Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.

Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
复制标题

DOI:
10.1007/s00380-018-1140-6
复制
发表时间:
2018-08
期刊:
影响因子:
1.5
通讯作者:
Shimokawa H
Shimokawa H
中科院分区:
医学4区
文献类型:
--
作者:
Kozu K;Sugimura K;Aoki T;Tatebe S;Yamamoto S;Yaoita N;Shimizu T;Nochioka K;Sato H;Konno R;Satoh K;Miyata S;Shimokawa H

文献摘要

参考文献

被引文献

相似文献

众所周知,肺动脉高压(PAH)在女性中的发病率较高,而男性患者的预后较差。然而,现代PAH靶向治疗的血流动力学反应和长期预后的性别差异仍有待充分阐明。我们检查了1999年4月至2014年10月在我院诊断的129例连续PAH患者(34例男性和95例女性)的长期预后,并评估了PAH靶向治疗的血流动力学变化。与男性患者相比,女性患者的5年生存率更高(74.0 vs. 53.4%,P = 0.003);然而,女性患者的年龄四分位数较高与不良结局相关。药物治疗后的随访检查显示,男性和女性的平均肺动脉压(mPAP)、肺血管阻力(PVR)和肺动脉容量(PAC)均显著降低(均P < 0.05),而只有女性的右心室舒张末期压(RVEDP),右心房压(RAP),心脏指数,混合静脉血氧饱和度(SvO 2)(均P < 0.05)。基线年龄仅在女性患者中与血流动力学变化显著相关,特别是RVEDP和RAP存在显著的性别交互作用(均P < 0.10)。多变量分析显示,男性患者基线时的SvO 2和随访时的mPAP和SvO 2是显著的预后因素,而女性患者mPAP、PVR和PAC的变化以及内皮素受体拮抗剂的使用是显著的预后因素。这些结果表明,女性PAH患者的长期预后优于男性,可能涉及右心室功能和血流动力学的更好改善。
It is widely known that the incidence of pulmonary arterial hypertension (PAH) is higher in female, whereas prognosis is poorer in male patients. However, sex differences in hemodynamic response to and long-term prognosis with PAH-targeted treatment in the modern era remain to be fully elucidated. We examined the long-term prognosis of 129 consecutive PAH patients (34 males and 95 females) diagnosed in our hospital from April 1999 to October 2014, and assessed hemodynamic changes in response to PAH-targeted therapy. Female patients had better 5-year survival compared with male patients (74.0 vs. 53.4%, P = 0.003); however, higher age quartiles in females were associated with poor outcome. Follow-up examination after medical treatment showed significant decreases in mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and pulmonary arterial capacitance (PAC) in both sexes (both P < 0.05), whereas only females had a significant improvement in right ventricular end-diastolic pressure (RVEDP), right atrial pressure (RAP), cardiac index, and mixed venous oxygen saturation (SvO2) (all P < 0.05). Baseline age significantly correlated with the hemodynamic changes only in female patients; particularly, there were significant sex interactions in RVEDP and RAP (both P < 0.10). The multivariable analysis showed that SvO2 at baseline and mPAP and SvO2 at follow-up were significant prognostic factors in males, whereas the changes in mPAP, PVR, and PAC and use of endothelin-receptor antagonist in females. These results indicate that female PAH patients have better long-term prognosis than males, for which better improvements of right ventricular functions and hemodynamics may be involved.
DOI: 10.1183/09059180.00008211
发表时间: 2012-03-01
影响因子: 7.5
作者:
McGoon, M. D.;Miller, D. P.
通讯作者: Miller, D. P.
DOI: 10.1152/ajplung.00006.2015
发表时间: 2015-05-01
影响因子: 4.9
作者:
Frump, Andrea L.;Goss, Kara N.;Lahm, Tim
通讯作者: Lahm, Tim
DOI: 10.1378/chest.08-1758
发表时间: 2009-03
期刊: Chest
影响因子: 9.6
作者:
Kawut SM;Al-Naamani N;Agerstrand C;Berman Rosenzweig E;Rowan C;Barst RJ;Bergmann S;Horn EM
通讯作者: Horn EM
DOI: 10.1183/09031936.00010409
发表时间: 2009-11
期刊: The European respiratory journal
影响因子: --
作者:
Austin ED;Cogan JD;West JD;Hedges LK;Hamid R;Dawson EP;Wheeler LA;Parl FF;Loyd JE;Phillips JA 3rd
通讯作者: Phillips JA 3rd
DOI: 10.1161/circulationaha.110.985515
发表时间: 2011-06-07
期刊: Circulation
影响因子: 37.8
作者:
Kawut SM;Lima JA;Barr RG;Chahal H;Jain A;Tandri H;Praestgaard A;Bagiella E;Kizer JR;Johnson WC;Kronmal RA;Bluemke DA
通讯作者: Bluemke DA